CA-125 was established as a prognostic marker in cancer, specifically in ovarian carcinoma (40) and the present results indicated that BRCA1 methylation and CA-125 levels, in combination, may be used as biomarkers for the diagnosis and prognosis of EOC. Here, BRCA1 is linked to cancer.